• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7213
Medical Device Problem Codes Break (1069); Material Rupture (1546)
Health Effect - Clinical Codes No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/01/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Event date: used the first day of the month of aware date since there was no date provided.
 
Event or Problem Description
It was reported that balloon rupture and shaft break occurred.The 95% stenosed target lesion was located in the moderately tortuous and moderately calcified vessel.A 3.00mm x 15mm nc emerge balloon catheter was advanced for dilatation.However, during the first inflation at 2 atmopheres, the balloon ruptured.The device was removed and the mid part of the shaft broke off.The procedure was completed with another of the same device.There were no complications reported and the patient was fine.
 
Additional Manufacturer Narrative
B3.Event date: used the first day of the month of aware date since there was no date provided.Device evaluated by mfr: returned product consisted of an nc emerge balloon catheter.The shaft, hypotube, tip and balloon were microscopically and visually examined.There were numerous kinks.There was a complete separation at 69.9cm distal of the strain relief.There was blood in the guidewire lumen.The balloon was tightly folded.The device was soaked in a water bath for three days to loosen the blood and contrast in the device.The device was prepped with an inflation device filled with water and connected to the inflation port to inflate the device.There were no issues detected.Inspection of the remainder of the device presented no other damage or irregularities.
 
Event or Problem Description
It was reported that balloon rupture and shaft break occurred.The 95% stenosed target lesion was located in the moderately tortuous and moderately calcified vessel.A 3.00mm x 15mm nc emerge balloon catheter was advanced for dilatation.However, during the first inflation at 2 atmospheres, the balloon ruptured.The device was removed and the mid part of the shaft broke off.The procedure was completed with another of the same device.There were no complications reported and the patient was fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC EMERGE
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10944578
Report Number2134265-2020-16797
Device Sequence Number3419385
Product Code LOX
UDI-Device Identifier08714729846529
UDI-Public08714729846529
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K141236
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 02/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/09/2022
Device Model Number7213
Device Catalogue Number7213
Device Lot Number0025987155
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/06/2021
Initial Date Received by Manufacturer 11/16/2020
Supplement Date Received by Manufacturer02/07/2021
Initial Report FDA Received Date12/04/2020
Supplement Report FDA Received Date02/15/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-